Clinical Research Directory
Browse clinical research sites, groups, and studies.
Beta-Adrenergic Modulation of Drug Cue Reactivity
Sponsor: University of Oklahoma
Summary
This study is designed to investigate the effects of a beta-adrenergic antagonist (Propranolol; 40 mg IR) and nicotine patch (14 mg) administered alone and in combination on neurobiological and behavioral responses to smoking cues in ongoing cigarette smokers. This is a basic experimental study in humans and participants will not take these medications for an extended period or make a cessation attempt as part of their involvement in this research project.
Official title: Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms
Key Details
Gender
All
Age Range
21 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2024-11-26
Completion Date
2026-03-01
Last Updated
2025-02-20
Healthy Volunteers
Yes
Interventions
Propranolol
Propranolol Capsule; 40 mg IR
Nicotine Patch
Nicotine Patch; 14 mg
Placebo Propranolol
Placebo Capsule, no active ingredients
Placebo Patch
Placebo Patch, no active ingredients
Locations (1)
Hardesty Center for Clinical Research and Neuroscience
Tulsa, Oklahoma, United States